Recombinant Human DEFB4

Description

EnkiLife provides the Recombinant Human DEFB4 protein,aslo know as Beta-Defensin 104,Beta-Defensin 4,BD-4,DEFB-4,hBD-4,Defensin Beta 104,DEFB104A,DEFB104,DEFB4,DEFB104B, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human Beta-Defensin 4 is produced by our E.coli expression system and the target gene encoding Glu23-Pro72 is expressed.Accession:Q8WTQ1. Expression Host:E.coli.Species:Human.Predicted Molecular Mass:5.99 KDa. Background:Defensins are cationic peptides. It is an important ingredient of the innate immune system. β-defensins are expressed on some leukocytes and epithelial surfaces. Four human β-Defensins have been identified to date: BD-1, BD-2, BD-3 and BD-4. β-defensins contain a six-cysteine motif, they forms three intra-molecular disulfide bonds. β-defensins are also chemoattractant towards immature dendritic cells and memory T cells. The β-defensin proteins are expressed as the C-terminal portion of precursors; they are released by proteolytic cleavage of a signal sequence.